Research Article

Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome

Table 2

Comparison of sleep characteristics between OSAS patients and controls.

OSAS patients (AHI > 5/h)
Control group (AHI < 5/h)

Recording time (min)366.95 ± 62.54381.40 ± 20.680.121
TST (min)310.28 ± 69.40291.95 ± 55.460.366
N1 (%)20.50 ± 19.4423.03 ± 14.970.643
N2 (%)65.60 ± 14.5053.93 ± 9.050.003
N3 (%)6.44 ± 7.2611.14 ± 8.670.133
REM (%)8.91 ± 6.7711.91 ± 10.190.390
RDI54.83 ± 29.912.54 ± 1.11<0.001
Aver. SpO2 (%)89.69 ± 3.2393.8 ± 2.34<0.001
Min SpO2 (%)69.06 ± 11.4088.50 ± 3.74<0.001
T < 90% (%)38.42 ± 26.650.75 ± 1.53<0.001
Arousal index40.62 ± 21.4914.34 ± 10.60<0.001
Sleep efficiency (%)81.80 ± 15.0576.55 ± 13.870.293
ESS score11.05 ± 5.549.70 ± 4.110.378

AHI: apnoea-hypopnoea index, Aver. SpO2: average oxyhaemoglobin saturation during sleep, ESS: Epworth sleepiness scale, Min SpO2: minimum oxyhaemoglobin saturation during sleep, N1: sleep stage 1, N2: sleep stage 2, N3: sleep stage 3, OSAS: obstructive sleep apnea syndrome, RDI: respiratory disturbance index, REM: rapid eye movement, TST: total sleep time, and T < 90%: time with oxyhaemoglobin saturation <90%.